{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:27:28Z","timestamp":1790116048400,"version":"4.0.1"},"reference-count":109,"publisher":"Japan Atherosclerosis Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026,5,1]]},"DOI":"10.5551\/jat.rv22048","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T22:10:47Z","timestamp":1772489447000},"page":"521-537","source":"Crossref","is-referenced-by-count":2,"title":["Two-Step Clinical Pathways to Cardiovascular Mortality in Chronic Kidney Disease and Dialysis -- A Narrative Review"],"prefix":"10.5551","volume":"33","author":[{"given":"Tetsuo","family":"Shoji","sequence":"first","affiliation":[{"name":"Clinical Research Center, Inoue Hospital"},{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[{"name":"Renal Research Unit, Department of Clinical Research and Epidemiology, University of Wurzburg"},{"name":"Clinical Trial Service and Epidemiology Studies Unit, Nuffield Department of Population Health, University of Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kannel WB, Dawber TR, Friedman GD, Glennon WE and McNamara PM: Risk Factors in Coronary Heart Disease. An Evaluation of Several Serum Lipids as Predictors of Coronary Heart Disease; the Framingham Study. Ann Intern Med, 1964; 61: 888-899","DOI":"10.7326\/0003-4819-61-5-888"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Ueda K, Omae T, Hirota Y, Takeshita M and Hiyoshi Y: Epidemiological and clinco-pathological study on renal diseases observed in the autopsy cases in Hisayama population, Kyushu Island, Japan. J Chronic Dis, 1976; 29: 159-173","DOI":"10.1016\/0021-9681(76)90043-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Go AS, Chertow GM, Fan D, McCulloch CE and Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med, 2004; 351: 1296-1305","DOI":"10.1056\/NEJMoa041031"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Foley RN, Parfrey PS and Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998; 32: S112-119","DOI":"10.1053\/ajkd.1998.v32.pm9820470"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW, American Heart Association Councils on Kidney in Cardiovascular Disease HBPRCC, Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation, 2003; 108: 2154-2169","DOI":"10.1161\/01.CIR.0000095676.90936.80"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA and Bergstrom J: Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant, 2000; 15: 953-960","DOI":"10.1093\/ndt\/15.7.953"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kalantar-Zadeh K, Kopple JD, Block G and Humphreys MH: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis, 2001; 38: 1251-1263","DOI":"10.1053\/ajkd.2001.29222"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Trevino-Becerra A and Wanner C: A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int, 2008; 73: 391-398","DOI":"10.1038\/sj.ki.5002585"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen G, Mitch WE, Price SR, Wanner C, Wang AY, ter Wee P and Franch HA: Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr, 2013; 23: 77-90","DOI":"10.1053\/j.jrn.2013.01.001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Calle EE, Thun MJ, Petrelli JM, Rodriguez C and Heath CW, Jr.: Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med, 1999; 341: 1097-1105","DOI":"10.1056\/NEJM199910073411501"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kalantar-Zadeh K, Rhee CM, Chou J, Ahmadi SF, Park J, Chen JL and Amin AN: The Obesity Paradox in Kidney Disease: How to Reconcile it with Obesity Management. Kidney Int Rep, 2017; 2: 271-281","DOI":"10.1016\/j.ekir.2017.01.009"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kalantar-Zadeh K, Anker SD, Coats AJ, Horwich TB and Fonarow GC: Obesity paradox as a component of reverse epidemiology in heart failure. Arch Intern Med, 2005; 165: 1797; author reply 1797-1798","DOI":"10.1001\/archinte.165.15.1797-a"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Nishizawa Y, Shoji T, Ishimura E, Inaba M and Morii H: Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia? Am J Kidney Dis, 2001; 38: S4-7","DOI":"10.1053\/ajkd.2001.27380"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Shoji T and Nishizawa Y: Chronic kidney disease as a metabolic syndrome with malnutrition--need for strict control of risk factors. Intern Med, 2005; 44: 179-187","DOI":"10.2169\/internalmedicine.44.179"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Wanner C, Amann K and Shoji T: The heart and vascular system in dialysis. Lancet, 2016; 388: 276-284","DOI":"10.1016\/S0140-6736(16)30508-6"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Iseki K and Fukiyama K: Long-term prognosis and incidence of acute myocardial infarction in patients on chronic hemodialysis. The Okinawa Dialysis Study Group. Am J Kidney Dis, 2000; 36: 820-825","DOI":"10.1053\/ajkd.2000.17676"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Iseki K, Fukiyama K and Okawa Dialysis Study G: Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. The Okinawa Dialysis Study (OKIDS) Group. Nephrol Dial Transplant, 2000; 15: 1808-1813","DOI":"10.1093\/ndt\/15.11.1808"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K, Wakugawa Y, Hata J, Oishi Y, Shikata K, Yonemoto K, Hirakata H and Iida M: Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int, 2005; 68: 228-236","DOI":"10.1111\/j.1523-1755.2005.00397.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Smith GL, Masoudi FA, Shlipak MG, Krumholz HM and Parikh CR: Renal impairment predicts long-term mortality risk after acute myocardial infarction. J Am Soc Nephrol, 2008; 19: 141-150","DOI":"10.1681\/ASN.2007050554"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Taniguchi M, Fukagawa M, Fujii N, Hamano T, Shoji T, Yokoyama K, Nakai S, Shigematsu T, Iseki K and Tsubakihara Y: Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients. Ther Apher Dial, 2013; 17: 221-228","DOI":"10.1111\/1744-9987.12030"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Goto S, Hamano T, Fujii H, Taniguchi M, Abe M, Nitta K and Nishi S: Hypocalcemia and cardiovascular mortality in cinacalcet users. Nephrol Dial Transplant, 2024; 39: 637-647","DOI":"10.1093\/ndt\/gfad213"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Joki N, Hase H, Nakamura R and Yamaguchi T: Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant, 1997; 12: 718-723","DOI":"10.1093\/ndt\/12.4.718"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Hase H, Tsunoda T, Tanaka Y, Takahashi Y, Imamura Y, Ishikawa H, Inishi Y and Joki N: Risk factors for de novo acute cardiac events in patients initiating hemodialysis with no previous cardiac symptom. Kidney Int, 2006; 70: 1142-1148","DOI":"10.1038\/sj.ki.5001726"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Shoji T, Emoto M, Tabata T, Kimoto E, Shinohara K, Maekawa K, Kawagishi T, Tahara H, Ishimura E and Nishizawa Y: Advanced atherosclerosis in predialysis patients with chronic renal failure. Kidney Int, 2002; 61: 2187-2192","DOI":"10.1046\/j.1523-1755.2002.00372.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Shinohara K, Shoji T, Tsujimoto Y, Kimoto E, Tahara H, Koyama H, Emoto M, Ishimura E, Miki T, Tabata T and Nishizawa Y: Arterial stiffness in predialysis patients with uremia. Kidney Int, 2004; 65: 936-943","DOI":"10.1111\/j.1523-1755.2004.00468.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Shoji T, Maekawa K, Emoto M, Okuno S, Yamakawa T, Ishimura E, Inaba M and Nishizawa Y: Arterial stiffness predicts cardiovascular death independent of arterial thickness in a cohort of hemodialysis patients. Atherosclerosis, 2010; 210: 145-149","DOI":"10.1016\/j.atherosclerosis.2009.11.013"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Shoji T, Emoto M, Shinohara K, Kakiya R, Tsujimoto Y, Kishimoto H, Ishimura E, Tabata T and Nishizawa Y: Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol, 2001; 12: 2117-2124","DOI":"10.1681\/ASN.V12102117"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Okuno S, Ishimura E, Kitatani K, Fujino Y, Kohno K, Maeno Y, Maekawa K, Yamakawa T, Imanishi Y, Inaba M and Nishizawa Y: Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis, 2007; 49: 417-425","DOI":"10.1053\/j.ajkd.2006.12.017"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Chen J, Budoff MJ, Reilly MP, Yang W, Rosas SE, Rahman M, Zhang X, Roy JA, Lustigova E, Nessel L, Ford V, Raj D, Porter AC, Soliman EZ, Wright JT, Jr., Wolf M, He J and Investigators C: Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease. JAMA Cardiol, 2017; 2: 635-643","DOI":"10.1001\/jamacardio.2017.0363"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Shoji T, Masakane I, Watanabe Y, Iseki K and Tsubakihara Y: Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients. Clin J Am Soc Nephrol, 2011; 6: 1112-1120","DOI":"10.2215\/CJN.09961110"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Ishimitsu T, Nakano N, Sudo Y, Akashiba A, Takahashi T, Ohta S, Minami J and Matsuoka H: Predictive significance of blood pressure values for the incidence of cardiovascular events in chronic hemodialysis patients. Hypertension research: official journal of the Japanese Society of Hypertension, 2008; 31: 1703-1709","DOI":"10.1291\/hypres.31.1703"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland S and Kopple JD: Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension, 2005; 45: 811-817","DOI":"10.1161\/01.HYP.0000154895.18269.67"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH and Teredesai P: \u201cU\u201d curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int, 1998; 54: 561-569","DOI":"10.1046\/j.1523-1755.1998.00005.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Shoji T, Tsubakihara Y, Fujii M and Imai E: Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int, 2004; 66: 1212-1220","DOI":"10.1111\/j.1523-1755.2004.00812.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G and Kidney Disease: Improving Global O: Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int, 2006; 69: 1945-1953","DOI":"10.1038\/sj.ki.5000414"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Yamada S and Nakano T: Role of Chronic Kidney Disease (CKD)-Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD. Journal of atherosclerosis and thrombosis, 2023; 30: 835-850","DOI":"10.5551\/jat.RV22006"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Cejka D, Haarhaus M, Pasch A, Smith ER, Chronic Kidney Disease M and Bone Disorder Working Group of the European Renal A: Calciprotein Particles and the Mineral Buffering System of Blood: Preventing the Toxicity of Mineral Stress. J Am Soc Nephrol, 2025;","DOI":"10.1681\/ASN.0000000863"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG and Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol, 2004; 15: 2208-2218","DOI":"10.1097\/01.ASN.0000133041.27682.A2"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Shoji T, Marubayashi S, Shigematsu T, Iseki K and Tsubakihara Y: Use of vitamin D receptor activator, incident cardiovascular disease and death in a cohort of hemodialysis patients. Ther Apher Dial, 2015; 19: 235-244","DOI":"10.1111\/1744-9987.12274"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Yamada S, Tsuruya K, Taniguchi M, Tokumoto M, Fujisaki K, Hirakata H, Fujimi S and Kitazono T: Association Between Serum Phosphate Levels and Stroke Risk in Patients Undergoing Hemodialysis: The Q-Cohort Study. Stroke, 2016; 47: 2189-2196","DOI":"10.1161\/STROKEAHA.116.013195"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Smith ER and Holt SG: The formation and function of calciprotein particles. Pflugers Arch, 2025;","DOI":"10.1007\/s00424-025-03083-7"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Pasch A, Farese S, Graber S, Wald J, Richtering W, Floege J and Jahnen-Dechent W: Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol, 2012; 23: 1744-1752","DOI":"10.1681\/ASN.2012030240"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Smith ER, Ford ML, Tomlinson LA, Bodenham E, McMahon LP, Farese S, Rajkumar C, Holt SG and Pasch A: Serum calcification propensity predicts all-cause mortality in predialysis CKD. J Am Soc Nephrol, 2014; 25: 339-348","DOI":"10.1681\/ASN.2013060635"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Pasch A, Block GA, Bachtler M, Smith ER, Jahnen-Dechent W, Arampatzis S, Chertow GM, Parfrey P, Ma X and Floege J: Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial. Clin J Am Soc Nephrol, 2017; 12: 315-322","DOI":"10.2215\/CJN.04720416"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Mori K, Emoto M and Inaba M: Fetuin-A: a multifunctional protein. Recent patents on endocrine, metabolic & immune drug discovery, 2011; 5: 124-146","DOI":"10.2174\/187221411799015372"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Mori K, Emoto M and Inaba M: Fetuin-A and the cardiovascular system. Adv Clin Chem, 2012; 56: 175-195","DOI":"10.1016\/B978-0-12-394317-0.00010-8"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Mori K, Shoji T, Nakatani S, Uedono H, Ochi A, Yoshida H, Imanishi Y, Morioka T, Tsujimoto Y, Kuro OM and Emoto M: Differential associations of fetuin-A and calcification propensity with cardiovascular events and subsequent mortality in patients undergoing hemodialysis. Clin Kidney J, 2024; 17: sfae042","DOI":"10.1093\/ckj\/sfae042"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Klahr S and Slatopolsky E: Toxicity of parathyroid hormone in uremia. Annu Rev Med, 1986; 37: 71-78","DOI":"10.1146\/annurev.me.37.020186.000443"},{"key":"49","unstructured":"49) Massry SG and Goldstein DA: The search for uremic toxin(s) \u201cX\u201d \u201cX\u201d = PTH. Clin Nephrol, 1979; 11: 181-189"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Nakaya R, Shoji T, Nagata Y, Nakatani S, Mori K, Morioka T, Tsujimoto Y and Emoto M: Associations of Serum Insulin-Like Growth Factor 1 with New Cardiovascular Events and Subsequent Death in Hemodialysis Patients: The DREAM Cohort. Journal of atherosclerosis and thrombosis, 2022; 29: 1153-1165","DOI":"10.5551\/jat.62992"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Russo D, Morrone LF, Errichiello C, De Gregorio MG, Imbriaco M, Battaglia Y, Russo L, Andreucci M and Di Iorio BR: Impact of BMI on cardiovascular events, renal function, and coronary artery calcification. Blood Purif, 2014; 38: 1-6","DOI":"10.1159\/000362862"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Kakiya R, Shoji T, Tsujimoto Y, Tatsumi N, Hatsuda S, Shinohara K, Kimoto E, Tahara H, Koyama H, Emoto M, Ishimura E, Miki T, Tabata T and Nishizawa Y: Body fat mass and lean mass as predictors of survival in hemodialysis patients. Kidney Int, 2006; 70: 549-556","DOI":"10.1038\/sj.ki.5000331"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Canaud B, Granger Vallee A, Molinari N, Chenine L, Leray-Moragues H, Rodriguez A, Chalabi L, Morena M and Cristol JP: Creatinine index as a surrogate of lean body mass derived from urea Kt\/V, pre-dialysis serum levels and anthropometric characteristics of haemodialysis patients. PloS one, 2014; 9: e93286","DOI":"10.1371\/journal.pone.0093286"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Arase H, Yamada S, Yotsueda R, Taniguchi M, Yoshida H, Tokumoto M, Nakano T, Tsuruya K and Kitazono T: Modified creatinine index and risk for cardiovascular events and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort study. Atherosclerosis, 2018; 275: 115-123","DOI":"10.1016\/j.atherosclerosis.2018.06.001"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Arase H, Yamada S, Hiyamuta H, Taniguchi M, Tokumoto M, Tsuruya K, Nakano T and Kitazono T: Modified creatinine index and risk for long-term infection-related mortality in hemodialysis patients: ten-year outcomes of the Q-Cohort Study. Sci Rep, 2020; 10: 1241","DOI":"10.1038\/s41598-020-58181-6"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) London GM, Marchais SJ, Guerin AP and Metivier F: Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens, 2005; 14: 525-531","DOI":"10.1097\/01.mnh.0000168336.67499.c0"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Wu X, Sun Z, Yao G and Zhou F: Left ventricular hypertrophy and cardiac valve calcification and their impacts on survival in maintenance hemodialysis patients: A retrospective cohort study. Medicine, 2025; 104: e44181","DOI":"10.1097\/MD.0000000000044181"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Okute Y, Shoji T, Hayashi T, Kuwamura Y, Sonoda M, Mori K, Shioi A, Tsujimoto Y, Tabata T, Emoto M and Inaba M: Cardiothoracic Ratio as a Predictor of Cardiovascular Events in a Cohort of Hemodialysis Patients. Journal of atherosclerosis and thrombosis, 2017; 24: 412-421","DOI":"10.5551\/jat.36426"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Sasaki S, Fujisaki K, Nishimura M, Nakano T, Abe M, Hanafusa N and Joki N: QT-Interval Prolongation and 1-Year Cardiac Death Among Patients Undergoing Hemodialysis. JACC Asia, 2025; 5: 122-124","DOI":"10.1016\/j.jacasi.2024.10.013"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Sasaki K, Shoji T, Kabata D, Shintani A, Okute Y, Tsuchikura S, Shimomura N, Tsujimoto Y, Nakatani S, Mori K, Shioi A, Inaba M and Emoto M: Oxidative Stress and Inflammation as Predictors of Mortality and Cardiovascular Events in Hemodialysis Patients: The DREAM Cohort. Journal of atherosclerosis and thrombosis, 2021; 28: 249-260","DOI":"10.5551\/jat.56069"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Uchida Y, Nakano T, Kitamura H, Taniguchi M, Tsuruya K and Kitazono T: Association between hyporesponsiveness to erythropoiesis-stimulating agents and risk of brain hemorrhage in patients undergoing hemodialysis: the Q-Cohort Study. Clin Exp Nephrol, 2023; 27: 79-88","DOI":"10.1007\/s10157-022-02278-x"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Kohara C, Yamada S, Tanaka S, Hiyamuta H, Kitamura H, Arase H, Shimamoto S, Taniguchi M, Tsuruya K, Kitazono T and Nakano T: Blood Hemoglobin Concentrations and the Incidence of Lower Extremity Peripheral Arterial Disease in Patients Undergoing Hemodialysis: 10-Year Outcomes of the Q-Cohort Study. Journal of the American Heart Association, 2024; 13: e033853","DOI":"10.1161\/JAHA.123.033853"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Shoji T, Niihata K, Fukuma S, Fukuhara S, Akizawa T and Inaba M: Both low and high serum ferritin levels predict mortality risk in hemodialysis patients without inflammation. Clin Exp Nephrol, 2017; 21: 685-693","DOI":"10.1007\/s10157-016-1317-1"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Iseki K, Tsubakihara Y, Isaka Y and Committee of Renal Data Registry of the Japanese Society for Dialysis T: Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study. PloS one, 2014; 9: e116273","DOI":"10.1371\/journal.pone.0116273"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Lacson E, Jr., Wang W, Ma L and Passlick-Deetjen J: Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study. Am J Kidney Dis, 2015; 66: 1056-1066","DOI":"10.1053\/j.ajkd.2015.06.014"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Nakatani S, Shoji T, Morioka F, Nakaya R, Ueda M, Uedono H, Tsuda A, Morioka T, Fujii H, Yoshida H, Mori K and Emoto M: Association between Serum Zinc and All-Cause Mortality in Patients Undergoing Maintenance Hemodialysis: The Osaka Dialysis Complication Study (ODCS). Nutrients, 2024; 16:","DOI":"10.3390\/nu16193270"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Tonelli M, Wiebe N, Bello A, Field CJ, Gill JS, Hemmelgarn BR, Holmes DT, Jindal K, Klarenbach SW, Manns BJ, Thadhani R, Kinniburgh D and Alberta Kidney Disease N: Concentrations of Trace Elements and Clinical Outcomes in Hemodialysis Patients: A Prospective Cohort Study. Clin J Am Soc Nephrol, 2018; 13: 907-915","DOI":"10.2215\/CJN.11451017"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Yamazaki Y, Shoji T, Miyashima M, Nagata Y, Kakutani Y, Ochi A, Morioka T, Nakatani S, Mori K, Tsujimoto Y and Emoto M: Low Free Triiodothyronine Level as a Predictor of Cardiovascular Events and All-Cause Mortality in Patients Undergoing Hemodialysis: The DREAM Cohort. Journal of atherosclerosis and thrombosis, 2021; 28: 1071-1082","DOI":"10.5551\/jat.60624"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Inaba M, Mori K, Tsujimoto Y, Yamada S, Yamazaki Y, Emoto M and Shoji T: Association of Reduced Free T3 to Free T4 Ratio with Lower Serum Creatinine in Japanese Hemodialysis Patients. Nutrients, 2021; 13:","DOI":"10.3390\/nu13124537"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Dalrymple LS, Katz R, Kestenbaum B, de Boer IH, Fried L, Sarnak MJ and Shlipak MG: The risk of infection-related hospitalization with decreased kidney function. Am J Kidney Dis, 2012; 59: 356-363","DOI":"10.1053\/j.ajkd.2011.07.012"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Chrysostomou C, Faustini F, Segelmark M, Carrero JJ, Gunnarsson I, Barany P, Evans M and Faucon AL: A national cohort study examined the risk of severe infection and infection-related mortality in patients with chronic kidney disease with lupus nephritis in comparison to other chronic kidney disease etiologies. Kidney Int, 2025;","DOI":"10.1016\/j.ekir.2024.10.021"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Bokhari SFH, Iqbal A, Usman S, Mushtaq U, Mukhtar Z and Naseer B: A comprehensive review of infection risks and management in hemodialysis access sites. Clin Exp Nephrol, 2025;","DOI":"10.1007\/s10157-025-02790-w"},{"key":"73","unstructured":"73) Nitta K, Goto S, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, Wada A, Hamano T, Hoshino J, Joki N, Abe M, Yamamoto K and Nakamoto H: Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality. Renal Replacement Therapy, 2020; 6: 41"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Dalrymple LS, Johansen KL, Chertow GM, Cheng SC, Grimes B, Gold EB and Kaysen GA: Infection-related hospitalizations in older patients with ESRD. Am J Kidney Dis, 2010; 56: 522-530","DOI":"10.1053\/j.ajkd.2010.04.016"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Dalrymple LS, Mu Y, Romano PS, Nguyen DV, Chertow GM, Delgado C, Grimes B, Kaysen GA and Johansen KL: Outcomes of infection-related hospitalization in Medicare beneficiaries receiving in-center hemodialysis. Am J Kidney Dis, 2015; 65: 754-762","DOI":"10.1053\/j.ajkd.2014.11.030"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76) Machiba Y, Mori K, Shoji T, Nagata Y, Uedono H, Nakatani S, Ochi A, Tsuda A, Morioka T, Yoshida H, Tsujimoto Y and Emoto M: Nutritional Disorder Evaluated by the Geriatric Nutritional Risk Index Predicts Death After Hospitalization for Infection in Patients Undergoing Maintenance Hemodialysis. J Ren Nutr, 2022; 32: 751-757","DOI":"10.1053\/j.jrn.2022.01.008"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77) Mori K, Yamamoto Y, Hanafusa N, Yamamoto S, Fukuma S, Onishi Y, Emoto M and Inaba M: Association of Nutritional Risk Index With Infection-Related Hospitalization and Death After Hospitalization in Patients Undergoing Maintenance Hemodialysis. J Ren Nutr, 2025; 35: 187-195","DOI":"10.1053\/j.jrn.2024.07.017"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78) Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA and Cardiovascular Health Study Collaborative Research G: Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci, 2001; 56: M146-156","DOI":"10.1093\/gerona\/56.3.M146"},{"key":"79","unstructured":"79) Nakai S, Shinzato T, Nagura Y, Masakane I, Kitaoka T, Shinoda T, Yamazaki C, Sakai R, Ohmori H, Morita O, Iseki K, Kikuchi K, Kubo K, Suzuki K, Tabei K, Fushimi K, Miwa N, Wada A, Yanai M, Akiba T and Patient Registration Committee JSfDTT: An overview of regular dialysis treatment in Japan (as of 31 December 2001). Ther Apher Dial, 2004; 8: 3-32"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80) Masaki T, Hanafusa N, Abe M, Joki N, Hoshino J, Taniguchi M, Kikuchi K, Hasegawa T, Goto S, Komaba H, Nakai S, Naganuma H, Fukuma S, Miura K, Yamamoto S, Wada A and Tomo M: 2023 Annual Dialysis Data Report, JSDT Renal Data Registry. Journal of the Japanese Society for Dialysis Therapy, 2024; 57: 543-620","DOI":"10.1186\/s41100-023-00478-z"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81) Dalrymple LS, Mohammed SM, Mu Y, Johansen KL, Chertow GM, Grimes B, Kaysen GA and Nguyen DV: Risk of cardiovascular events after infection-related hospitalizations in older patients on dialysis. Clin J Am Soc Nephrol, 2011; 6: 1708-1713","DOI":"10.2215\/CJN.10151110"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82) Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E, German D and Dialysis Study I: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med, 2005; 353: 238-248","DOI":"10.1056\/NEJMoa043545"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83) Fellstr\u00f6m BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Gronhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Suleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wuthrich RP, Gottlow M, Johnsson E, Zannad F and Group AS: Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med, 2009; 360: 1395-1407","DOI":"10.1056\/NEJMoa0810177"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84) Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T and Nishizawa Y: Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant, 2004; 19: 179-184","DOI":"10.1093\/ndt\/gfg513"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85) Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA, Jr. and Thadhani R: Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol, 2005; 16: 1115-1125","DOI":"10.1681\/ASN.2004070573"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86) Kovesdy CP and Kalantar-Zadeh K: Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int, 2008; 73: 1355-1363","DOI":"10.1038\/ki.2008.35"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87) Shoji T, Inaba M, Fukagawa M, Ando R, Emoto M, Fujii H, Fujimori A, Fukui M, Hase H, Hashimoto T, Hirakata H, Honda H, Hosoya T, Ikari Y, Inaguma D, Inoue T, Isaka Y, Iseki K, Ishimura E, Itami N, Ito C, Kakuta T, Kawai T, Kawanishi H, Kobayashi S, Kumagai J, Maekawa K, Masakane I, Minakuchi J, Mitsuiki K, Mizuguchi T, Morimoto S, Murohara T, Nakatani T, Negi S, Nishi S, Nishikawa M, Ogawa T, Ohta K, Ohtake T, Okamura M, Okuno S, Shigematsu T, Sugimoto T, Suzuki M, Tahara H, Takemoto Y, Tanaka K, Tominaga Y, Tsubakihara Y, Tsujimoto Y, Tsuruya K, Ueda S, Watanabe Y, Yamagata K, Yamakawa T, Yano S, Yokoyama K, Yorioka N, Yoshiyama M and Nishizawa Y: Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial. Jama, 2018; 320: 2325-2334","DOI":"10.1001\/jama.2018.17749"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88) Bauersachs J: Heart failure drug treatment: the fantastic four. European heart journal, 2021; 42: 681-683","DOI":"10.1093\/eurheartj\/ehaa1012"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89) American Diabetes Association Professional Practice Committee for D: 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026. Diabetes care, 2026; 49: S216-S245","DOI":"10.2337\/dc26-S010"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90) Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE and Investigators E-RO: Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med, 2015; 373: 2117-2128","DOI":"10.1056\/NEJMoa1504720"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91) Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jodar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsboll T and Investigators S-: Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med, 2016; 375: 1834-1844","DOI":"10.1056\/NEJMoa1607141"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92) Chen TH, Hu EH, Chen DY, Lin Y, Chou TS, Lin MS, Yang NI, Wang CY, Hung MJ and Tsai ML: GLP-1 RAs and Cardiovascular and Kidney Outcomes by Body Mass Index in Type 2 Diabetes. JAMA Netw Open, 2025; 8: e2530952","DOI":"10.1001\/jamanetworkopen.2025.30952"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93) Lok CE, Farkouh M, Hemmelgarn BR, Moist LM, Polkinghorne KR, Tomlinson G, Tam P, Tonelli M, Udell JA and Investigators P: Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis. N Engl J Med, 2025;","DOI":"10.1056\/NEJMoa2513032"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94) Shoji T, Kakiya R, Hayashi T, Tsujimoto Y, Sonoda M, Shima H, Mori K, Fukumoto S, Tahara H, Shioi A, Tabata T, Emoto M, Nishizawa Y and Inaba M: Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients. Am J Kidney Dis, 2013; 62: 568-576","DOI":"10.1053\/j.ajkd.2013.02.362"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95) van Koningsveld-Couperus BH, de Rooij T, van Meeteren NL, Preckel B, Hollmann MW and Nieuwenhuijs-Moeke GJ: Prehabilitation: A Catalyst for Transforming Toward Value-Based, Personalized Perioperative Health and Care. J Clin Med, 2025; 14:","DOI":"10.3390\/jcm14196747"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96) Yang M, Yang Y, Xu Y, Wu Y, Lin J, Mai J, Fang K, Ma X, Zou C and Lin Q: Development and Validation of Prediction Models for All-Cause Mortality and Cardiovascular Mortality in Patients on Hemodialysis: A Retrospective Cohort Study in China. Clinical interventions in aging, 2023; 18: 1175-1190","DOI":"10.2147\/CIA.S416421"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97) Nishizawa Y, Shoji T, Kakiya R, Tsujimoto Y, Tabata T, Ishimura E, Nakatani T, Miki T and Inaba M: Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease. Kidney Int Suppl, 2003; S117-120","DOI":"10.1046\/j.1523-1755.63.s84.30.x"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98) Chong CH, Au EH, Davies CE, Jaure A, Howell M, Lim WH, Craig JC, Teixeira-Pinto A and Wong G: Long-term Trends in Infection-Related Mortality in Adults Treated With Maintenance Dialysis. Am J Kidney Dis, 2023; 82: 597-607","DOI":"10.1053\/j.ajkd.2023.03.018"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99) Wakasugi M and Narita I: Sex Differences in Cause-specific Mortality in Japanese Dialysis Patients. Intern Med, 2022; 61: 2831-2839","DOI":"10.2169\/internalmedicine.8981-21"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100) Sumida K, Yamagata K, Iseki K and Tsubakihara Y: Different impact of hemodialysis vintage on cause-specific mortality in long-term hemodialysis patients. Nephrol Dial Transplant, 2016; 31: 298-305","DOI":"10.1093\/ndt\/gfv402"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101) Guo H, Zhang L, He H and Wang L: Risk factors for catheter-associated bloodstream infection in hemodialysis patients: A meta-analysis. PloS one, 2024; 19: e0299715","DOI":"10.1371\/journal.pone.0299715"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102) Hannane N, Mayer CC, Matschkal J, Bormann F, Krieter A, Braun JR, Kuchle C, Renders L, Gunthner R, Schmidt G, Muller A, Wassertheurer S, Heemann U, Haller B, Malik M, Schmaderer C and Braunisch MC: Long-term prediction of mortality by heart rate turbulence in hemodialysis patients and the impact of diabetes mellitus-a longitudinal observational study. J Nephrol, 2025; 38: 2261-2272","DOI":"10.1007\/s40620-025-02357-8"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103) Li T, Liu J, An S, Dai Y and Yu Q: Body mass index and mortality in patients on maintenance hemodialysis: a meta-analysis. Int Urol Nephrol, 2014; 46: 623-631","DOI":"10.1007\/s11255-014-0653-x"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104) Dadson P, Tetteh CD, Rebelos E, Badeau RM and Moczulski D: Underlying Kidney Diseases and Complications for COVID-19: A Review. Front Med (Lausanne), 2020; 7: 600144","DOI":"10.3389\/fmed.2020.600144"},{"key":"105","doi-asserted-by":"crossref","unstructured":"105) Yeun JY, Levine RA, Mantadilok V and Kaysen GA: C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis, 2000; 35: 469-476","DOI":"10.1016\/S0272-6386(00)70200-9"},{"key":"106","doi-asserted-by":"crossref","unstructured":"106) Hung KC, Kao CL, Hsu CW, Yu CH, Lin CM, Chen HT, Chang YJ, Liao SW and Chen IW: Impact of the geriatric nutritional risk index on long-term outcomes in patients undergoing hemodialysis: a meta-analysis of observational studies. Front Nutr, 2024; 11: 1346870","DOI":"10.3389\/fnut.2024.1346870"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107) Shimamoto S, Yamada S, Hiyamuta H, Arase H, Taniguchi M, Tsuruya K, Nakano T and Kitazono T: Association of the nutritional risk index for Japanese hemodialysis patients with long-term mortality: The Q-Cohort Study. Clin Exp Nephrol, 2022; 26: 59-67","DOI":"10.1007\/s10157-021-02124-6"},{"key":"108","doi-asserted-by":"crossref","unstructured":"108) Kaysen GA, Grimes B, Dalrymple LS, Chertow GM, Ishida JH, Delgado C, Segal M, Chiang J, Dwyer T and Johansen KL: Associations of lipoproteins with cardiovascular and infection-related outcomes in patients receiving hemodialysis. Journal of clinical lipidology, 2018; 12: 481-487 e414","DOI":"10.1016\/j.jacl.2017.12.007"},{"key":"109","doi-asserted-by":"crossref","unstructured":"109) Lee JE, Lim JH, Jang HM, Kim YS, Kang SW, Yang CW, Kim NH, Kwon E, Kim HJ, Park JM, Jung HY, Choi JY, Park SH, Kim CD, Cho JH, Kim YL and Clinical Research Center for End Stage Renal Disease I: Low serum phosphate as an independent predictor of increased infection-related mortality in dialysis patients: A prospective multicenter cohort study. PloS one, 2017; 12: e0185853","DOI":"10.1371\/journal.pone.0185853"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/5\/33_RV22048\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:25:38Z","timestamp":1777692338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/5\/33_RV22048\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":109,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.rv22048","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"RV22048"}}